Literature DB >> 12760855

Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000.

Marja Pihlajamäki1, Jari Jalava, Pentti Huovinen, Pirkko Kotilainen.   

Abstract

The resistance patterns and macrolide resistance mechanisms of 910 Finnish invasive pneumococci isolated during 1999 and 2000 were studied. Macrolide resistance was detected in 6.9% of isolates. Penicillin resistance was detected in 1.5% of isolates, and penicillin intermediate resistance was detected in 4.0% of isolates. Active macrolide efflux, mediated by the mef(A) gene, was the most common macrolide resistance mechanism. Four macrolide-resistant isolates had mutations in rRNA or ribosomal protein L22.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12760855      PMCID： PMC155848          DOI： 10.1128/AAC.47.6.1832-1835.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment.

Authors:  K Gay; W Baughman; Y Miller; D Jackson; C G Whitney; A Schuchat; M M Farley; F Tenover; D S Stephens
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Authors:  Ralf René Reinert; Adnan Al-Lahham; Maria Lemperle; Christoph Tenholte; Claudia Briefs; Stefan Haupts; Hans Hubert Gerards; Rudolf Lütticken
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

4.  Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000.

Authors:  Marja Pihlajamäki; Tarja Kaijalainen; Pentti Huovinen; Jari Jalava
Journal:  J Antimicrob Chemother       Date:  2002-05       Impact factor: 5.790

5.  Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life.

Authors:  G A Syrogiannopoulos; I N Grivea; T A Davies; G D Katopodis; P C Appelbaum; N G Beratis
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque.

Authors:  P Angot; M Vergnaud; M Auzou; R Leclercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

7.  In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.

Authors:  J Jalava; J Kataja; H Seppälä; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Authors:  Marja Pihlajamäki; Janne Kataja; Helena Seppälä; John Elliot; Maija Leinonen; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

Authors:  G A Syrogiannopoulos; I N Grivea; A Tait-Kamradt; G D Katopodis; N G Beratis; J Sutcliffe; P C Appelbaum; T A Davies
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

10.  Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens.

Authors:  D I Berryman; J I Rood
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191
View more
  12 in total

1.  Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.

Authors:  M Rantala; S Huikko; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 2.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Optimal therapy for severe pneumococcal community-acquired pneumonia.

Authors:  Manel Luján; Miguel Gallego; Jordi Rello
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

4.  High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Nicole Wolter; Anthony M Smith; Donald E Low; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

5.  Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.

Authors:  Paulina A Hawkins; Sopio Chochua; Delois Jackson; Bernard Beall; Lesley McGee
Journal:  Microb Drug Resist       Date:  2014-08-12       Impact factor: 3.431

6.  Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway.

Authors:  P Littauer; M Sangvik; D A Caugant; E A Høiby; G S Simonsen; A Sundsfjord
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 7.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.

Authors:  Lotta Siira; Merja Rantala; Jari Jalava; Antti J Hakanen; Pentti Huovinen; Tarja Kaijalainen; Outi Lyytikäinen; Anni Virolainen
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

9.  Low incidence of antibiotic resistance among invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Philippines between 1994 and 2000.

Authors:  L Sombrero; A Nissinen; G Esparar; M Lindgren; L Siira; A Virolainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-01       Impact factor: 3.267

10.  Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae.

Authors:  Maria Del Grosso; Anna Scotto d'Abusco; Francesco Iannelli; Gianni Pozzi; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.